Amber Therapeutics

Amber Therapeutics is an Oxford-based bioelectronics medtech company developing next-generation implantable neuromodulation devices for pelvic and nervous system disorders such as overactive bladder. Spun out from the University of Oxford, the company combines advanced microelectronics with closed-loop stimulation algorithms that adapt treatment in real time based on patient physiology. Amber has raised funding from deep-tech and life-science investors to advance its platform through clinical development. The company represents a growing wave of UK-based bioelectronic medicine startups tackling chronic conditions with precision device therapies.